Diabetes continues to be a leading cause of death in society due to its increased risks and other factors facilitating its prevalence. Research suggests that there exist two types of diabetes type 1 diabetes is described as the production of low or no insulin by the pancreas (Miller, Anderson, Costacou, Sekikawa & Orchard, 2018). Type 2 diabetes, on the other hand, involves the production of some levels of insulin that prove to be insufficient for the body. The relationship between hemoglobin and type 1 diabetes is significant as studies reveal that such factors are influenced by age, sex, and condition of a patient. For example, scholars found that hemoglobin levels were higher in adolescent females diagnosed with type 1 diabetes (Miller et al., 2018). Similarly, hemoglobin levels in the diagnosed population depicted a decline during the early adulthood phase, specifically in the male population hence the need to evaluate the cause. Scholars then concluded that hemoglobin levels of men within that age bracket declined due to the development of other renal issues such as kidney disease (Miller et al., 2018). Conversely, the relationship between hemoglobin and type 2 diabetes is similarly crucial based on the fact that patients diagnosed with type 2 diabetes consequently suffer from anemia (Zhang, Hu, Yuan & Chen, 2012). This is because the hemoglobin levels in such patients are lower. The heart, on the other hand, is a sensitive organ that is affected significantly by the high levels of hemoglobin found in type 1 diabetes patients. Further studies reveal that almost half of type 1 diabetes patients without a medical history of the cardiovascular disease develop the same after a prolonged extended period (Miller et al., 2018). Moreover, type 2 diabetes invokes cardiovascular diseases. Studies reveal that cardiovascular disease accounts for 75% of deaths among patients who have a specific type of diabetes (Zhang et al., 2012). In conclusion, diabetes is a significant public health issue that continues to affect the world on a global scale.
References
Miller, R. G., Anderson, S. J., Costacou, T., Sekikawa, A., & Orchard, T. J. (2018). Hemoglobin A1c level and cardiovascular disease incidence in persons with type 1 diabetes: an application of joint modeling of longitudinal and time-to-event data in the Pittsburgh Epidemiology of Diabetes Complications Study. American journal of epidemiology , 187 (7), 1520-1529.
Delegate your assignment to our experts and they will do the rest.
Zhang, Y., Hu, G., Yuan, Z., & Chen, L. (2012). Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PloS one , 7 (8), e42551.
